MMA
AVXL icon

Miracle Mile Advisors’s Anavex Life Sciences AVXL Stock Holding History

Miracle Mile Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,492
Closed -$144K – 509
2023
Q4 		$144K Hold
15,492
– – ﹤0.01% 473
2023
Q3 		$101K Hold
15,492
– – ﹤0.01% 468
2023
Q2 		$126K Buy
+15,492
New +$133K ﹤0.01% 490
2023
Q1 		– Sell
-10,547
Closed -$97.7K – 514
2022
Q4 		$97.7K Buy
+10,547
New +$113K ﹤0.01% 495
2021
Q4 		– Sell
-61,656
Closed -$1.11M – 447
2021
Q3 		$1.11M Buy
+61,656
New +$1.23M 0.05% 215

Other funds holding AVXL

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Miracle Mile Advisors's AVXL Position: Q1 2024 in Review

Miracle Mile Advisors sold out of Anavex Life Sciences (AVXL) in Q1 2024, closing a stake of 15,492 shares — an estimated $144K sold.

Miracle Mile Advisors first reported a position in AVXL in Q3 2021 and held it in 5 quarters. The position peaked at $1.11M in Q3 2021. 147 funds tracked by Wall St. Rank hold AVXL as of Q1 2024.

  • Miracle Mile Advisors reported no remaining Anavex Life Sciences position as of Q1 2024 after selling out during the quarter.
  • Miracle Mile Advisors sold 15,492 Anavex Life Sciences shares in Q1 2024, an estimated $144K.
  • Miracle Mile Advisors first reported a position in Anavex Life Sciences in Q3 2021 and held it in 5 quarters.
  • Miracle Mile Advisors's Anavex Life Sciences position peaked at $1.11M in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2024.

Based on Miracle Mile Advisors's 13F filing for Q1 2024, filed 18 Apr 2024.